Health
New anti-cancer drug breakthrough for prostate cancer – Mirage News
Novel anti-cancer agents induce the degradation of the c-Met oncoprotein in the lysosome as demonstrated by confocal microscopy in tumour cells A new…
A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.
Developed by Griffith University researcher Professor Des Richardson and colleagues from the University of Sydney, the drug known as DpC inhibits prostate specific antigen (PSA) as well as suppressing both androgen-dependent and independent arms of androgen receptor signalling.
“The current gold standard for prostate cancer treatment …
-
Noosa News23 hours agoWhy Brisbane needs to (re)embrace Los Angeles
-
Noosa News20 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General23 hours agoAustralia retains Chappell-Hadlee Trophy after rain washes out second T20I against New Zealand
-
General22 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England